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Abstract – 390 Words 
While numerous changes in the GABA system have been identified in models of Fragile X Syndrome 
(FXS), alterations in subunits of the GABAA receptors (GABAARs) that mediate tonic inhibition are 
particularly intriguing.  Considering the key role of tonic inhibition in controlling neuronal excitability, 
reduced tonic inhibition could contribute to FXS-associated disorders such as hyperactivity, 
hypersensitivity, and increased seizure susceptibility.  The current study has focused on the expression 
and function of the δ subunit of the GABAAR, a major subunit involved in tonic inhibition, in granule 
cells of the dentate gyrus in the Fmr1 knockout (KO) mouse model of FXS.   Electrophysiological studies 
of dentate granule cells revealed a marked, nearly four-fold, decrease in tonic inhibition in the Fmr1 KO 
mice, as well as reduced effects of two δ subunit-preferring pharmacological agents, THIP and DS2, 
supporting the suggestion that δ subunit-containing GABAARs are compromised in the Fmr1 KO mice.   
Immunohistochemistry demonstrated a small but statistically significant decrease in δ subunit labeling in 
the molecular layer of the dentate gyrus in Fmr1 KO mice compared to wildtype (WT) littermates.  The 
discrepancy between the large deficits in GABA-mediated tonic inhibition in granule cells in the Fmr1 
KO mice and only modest reductions in immunolabeling of the δ subunit led to studies of surface 
expression of the δ subunit.  Cross-linking experiments followed by Western blot analysis demonstrated a 
small, non-significant decrease in total δ subunit protein in the hippocampus of Fmr1 KO mouse, but a 
six-fold decrease in surface expression of the δ subunit in the Fmr1 KO mice.  No significant changes 
were observed in total or surface expression of the α4 subunit protein, a major partner of the δ subunit in 
the forebrain.  Postembedding immunogold labeling for the δ subunit demonstrated a large, three-fold, 
decrease in the number of symmetric synapses with immunolabeling at perisynaptic locations in Fmr1 
KO mice.  While α4 immunogold particles were also reduced at perisynaptic locations in the Fmr1 KO 
mice, the labeling was increased at synaptic sites.  Together these findings suggest that, in the dentate 
gyrus, altered surface expression of the δ subunit, rather than a decrease in δ subunit expression alone, 
could be limiting δ subunit-mediated tonic inhibition in this model of FXS.  Finding ways to increase 
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surface expression of the δ subunit of the GABAAR could be a novel approach to treatment of 
hyperexcitability-related alterations in FXS.   
 
Key words:  GABA receptor, Tonic inhibition, Dentate gyrus, Fmr1 gene, Fragile X mental retardation 
protein, Fragile X Syndrome 
 
Highlights   
Tonic inhibition is reduced in the dentate gyrus in a model of Fragile X Syndrome.  
Surface expression of GABAAR δ subunits is significantly reduced in this FXS model.  
Labeling of the δ subunit is reduced at perisynaptic locations in the Fmr1 KO mouse.  
Labeling of the α4 subunit is increased at synaptic locations in the Fmr1 KO mouse. 
Decreased surface expression of the δ subunit limits tonic inhibition in this model.  
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Introduction  
Fragile X syndrome (FXS) is the most common form of inherited cognitive impairment in humans and 
results from loss of function of the Fmr1 gene that encodes the fragile X mental retardation protein 
(FMRP) (Kooy et al., 2000).  This RNA-binding protein has many functions that include regulation of 
translation and transport of a subset of mRNAs into the dendrites and, through such functions, influences 
synapse development and plasticity (Bassell and Warren, 2008; Pfeiffer and Huber, 2009) for reviews).  
Loss of FMRP function affects multiple neurotransmitter and signaling systems, including the GABA 
system (D'Hulst and Kooy, 2009; Santoro et al., 2012).  While numerous types of alterations in the 
GABA system have been reported (D'Hulst et al., 2009; Paluszkiewicz et al., 2011) for reviews, a 
reduction in GABAA receptor (GABAAR)-mediated tonic inhibition is particularly intriguing, both as a 
basic functional change in FXS and as a target for treatment.  Tonic inhibition provides a powerful control 
of neuronal excitability (Brickley and Mody, 2012; Otis et al., 1991; Semyanov et al., 2004), and a 
decrease in tonic inhibition could contribute to the increased network excitability that is often observed in 
models of FXS (Gibson et al., 2008; Goncalves et al., 2013) and thus be associated with behavioral 
changes such as hyperactivity, hypersensitivity to sensory stimuli, and increased seizure susceptibility 
(Contractor et al., 2015).    
 Although several GABAAR subunits can be involved in tonic inhibition, the δ subunit is a critical 
subunit in several major brain regions, including the dentate gyrus, and expression of the δ subunit 
conveys special properties  (Brickley and Mody, 2012).  δ Subunit-containing GABAARs are located at 
extra- and perisynaptic sites, where they are ideally positioned to respond to ambient levels of GABA 
within the extracellular space or to spillover at the synapse; they have a high affinity for GABA and slow 
rates of desensitization; and, importantly, they are extremely sensitive to endogenous compounds such as 
neuroactive steroids (Saxena and Macdonald, 1994; Wei et al., 2003; Wohlfarth et al., 2002).  As a result 
of these properties, δ subunit-containing GABAARs can be modulated continuously to help maintain the 
general level of excitability of neuronal networks (Belelli et al., 2009; Olsen and Sieghart, 2008; Sun et 
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al., 2004; Wei et al., 2002).  Interestingly, the δ subunit mRNA was one of the first mRNAs to be 
identified as a direct target of FMRP (Miyashiro et al., 2003).  If lack of FMRP leads to altered translation 
or transport of δ subunit mRNA or dysregulation of δ subunit expression and function, such changes 
could be associated with deficits in tonic inhibition and potentially constitute a key alteration in FXS. 
 Despite considerable interest in GABAARs in FXS, GABA-mediated tonic inhibition has been 
studied in only a limited number of brain regions, such as the subiculum and basolateral nucleus of the 
amygdala (Curia et al., 2009; Olmos-Serrano et al., 2010).    Although tonic inhibition is prominent and 
mediated primarily by δ subunit-containing GABAARs in several major forebrain regions such as the 
dentate gyrus, alterations of δ-mediated tonic inhibition have been studied in FXS.  Altered tonic 
inhibition in the dentate gyrus could be quite important in FXS as this region serves as a gateway to the 
hippocampus and regulates the large amount of incoming information from the entorhinal cortex.  
Reduced control of granule cell activity in the dentate gyrus can lead to increased excitability throughout 
the hippocampal circuit and contribute to deficits in learning and memory as well as increased seizure 
susceptibility, conditions that are found in children with FXS (Berry-Kravis, 2002; Hagerman and 
Stafstrom, 2009; Musumeci et al., 1999).    
 The major goals of this study were to determine if tonic inhibition is impaired in dentate granule 
cells in the Fmr1 KO mouse model of FXS and if such changes are accompanied by alterations in the 
expression and localization of the δ subunit of the GABAAR in the dentate gyrus, using immunolabeling 
and biochemical methods.  The findings suggest that decreased surface expression of the δ subunit, rather 
than a decrease in δ subunit expression alone, is likely limiting tonic inhibition in the dentate gyrus and 
add to the growing evidence for deficits in δ subunit-mediated tonic inhibition in FXS.  Preliminary 
reports have been presented previously (Houser et al., 2014; Zhang et al., 2016). 
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Methods 
Animals 
Fmr1 KO male mice on a C57BL/6 background and their male wild-type (WT) littermates were used for 
all experiments.  Fmr1 KO mice were originally obtained from Dr. William Greenough (University of 
Illinois at Urbana-Champaign) and bred at the University of California, Los Angeles.  Genotypes were 
determined by PCR analysis of DNA extracted from tail samples.  After weaning, mice were housed in 
mixed genotype groups of the same sex under standard laboratory conditions with a 12:12 h light-dark 
cycle.  Animals for immunohistochemical studies were studied from postnatal day (PN) 14-60, and those 
for electrophysiological and biochemical studies were studied at 2-3 months of age.  Data from 34 Fmr1 
WT and 35 Fmr1 KO littermates were used in the study, and animal numbers are indicated for each 
experiment.  All animal use protocols conformed to National Institutes of Health guidelines and were 
approved by the University of California, Los Angeles, Chancellor’s Animal Research Committee.            
Immunohistochemistry 
Tissue preparation for light microscopy.  All mice used for light microscocpic immunohistochemical 
studies were deeply anesthetized with sodium pentobarbital (90 mg/kg, i.p.) and perfused transcardially 
with 4% paraformaldehyde in 0.12 M phosphate buffer, pH 7.3.  After 1 h at 4°C, brains were removed 
and postfixed for 1 h.  After rinsing, brains were cryoprotected in a 30% sucrose solution overnight at 4°C 
and frozen in cryo embedding compound on dry ice.  Forebrain blocks containing the hippocampus were 
sectioned coronally at 30 µM with a cryostat.    
Antisera and immunohistochemical methods.  The following GABAAR subunit-specific antisera 
were used to localize δ and α4 subunits in the immunohistochemical studies: rabbit anti δ subunit (1:000; 
Millipore AB9752 or PhosphoSolutions 868-GDN, no longer commercially available) and rabbit anti α4 
subunit (1:1000; Millipore AB5457).  The specificity of each antiserum was confirmed by a lack of 
immunohistochemical labeling in tissue from δ and α4 subunit KO animals, respectively (Peng et al., 
2002; Peng et al., 2014).  Prior to immunohistochemistry, free-floating sections were incubated in 1% 
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H2O2 for 30 min and then processed with a water bath heating antigen-retrieval method to reduce 
endogenous peroxidase-like activity and enhance specific labeling of the receptor subunits (Peng et al., 
2002).  Briefly, the sections were heated to 90°C for 70 min in sodium citrate solution (pH 8.6).  After 
cooling and rinsing in 0.1 M Tris buffered saline (TBS, pH 7.3), sections were processed for 
immunohistochemistry with standard avidin-biotin-peroxidase methods (Vectastain Elite ABC; Vector 
Laboratories) as described in detail previously (Peng et al, 2002; Peng pilo 2004).   
Densitometry methods.  The intensity of immunolabeling was analyzed with an Axioplan 2 
microscope equipped with an AxioCam digital camera system and AxioVision 4.6 software. (Zeiss). To 
evaluate possible differences in density of GABAAR subunit labeling in the Fmr1 WT and KO mice, 
sections from each animal at comparable levels of the hippocampus were processed in the same 
experimental run with identical conditions for each subunit.  Linear black and white digital images of 
immunolabeling in the dentate molecular layer, from each side of the brain, were obtained under identical 
conditions on the same day with stabilized light levels for densitometric analysis (n=2-5 animals per 
group at each age; 4-6 samples per animal for each subunit) .  The entire molecular layer of the dentate 
gyrus was outlined in each image, and the densities of labeling (grey values) within this region were 
determined with morphometric AxioVision software (version 4.6; Zeiss).  Data were analyzed with 
Student's t-test, and p < 0.05 was considered statistically significant.     
Immunogold Labeling for Electron Microscopy 
Tissue preparation.  Three pairs of Fmr1 WT and KO animals were prepared for postembedding 
immunogold labeling for the α4 and δ subunits of GABAARs, as described previously (Zhang et al., 
2007).  Following perfusion of the animals with 4% paraformaldehyde and 0.1% glutaraldehyde, brain 
sections were cut coronally at 0.5–1 mm with a razor blade, and small blocks of the dentate gyrus were 
trimmed from these sections. Specimens were cryoprotected, frozen at −190°C in a cryofixation unit (EM 
CPC; Leica), and then transferred to a cryosubstitution unit (EM AFS; Leica), which was programmed for 
all subsequent steps (Zhang et al., 2007). Specimens were immersed in 4% uranyl acetate (Electron 
Microscopy Sciences), dissolved in anhydrous methanol for 24 h at −90°C, rinsed in methanol at −45°C, 
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and infiltrated with Lowicryl HM20 resin (Electron Microscopy Sciences) for 48 h at −45°C. The resin 
was polymerized with ultraviolet light (360 nm) for 24 h at −45°C and then warmed in 4°C steps to 0°C. 
Immunogold labeling.  Ultrathin sections were cut on a microtome (Reichert-Jung, Vienna, Austria), 
picked up on nickel mesh grids, and processed for immunogold labeling with previously described 
methods (Peng et al., 2014; Zhang et al., 2007).   After appropriate pre-treatment, sections were incubated 
in primary antiserum, rabbit anti-δ subunit (1:100; AB9752, Millipore or 868-GDN, PhosphoSolutions, 
no longer available) or rabbit anti-α4 subunit (1:200; AB5457, Millipore) in TBS containing 2% human 
serum albumin (HSA) for 18–24 h at room temperature. Sections were then incubated for 2.5 h in the 
secondary antisera, goat anti-rabbit IgG or F(ab’)2 fragment of goat-anti-rabbit IgG (Aurion; distributed 
by Electron Microscopy Sciences) conjugated to 10 nm colloidal gold particles, diluted 1:30 in 
0.05 M TBS, pH 8.0, containing 2% HSA.  After immunogold processing, sections were stained with 
uranyl acetate for 40 min and lead citrate for 4 min.  
Quantitative analysis.  Randomly selected series of α4 or δ subunit-labeled synaptic profiles within 
the molecular layer of the dentate gyrus were photographed with a JEOL 100CX II electron microscope at 
a primary magnification of 19,000x. The localization of colloidal gold particles was determined for each 
symmetric synapse in the photomicrographs.  Symmetric synaptic contacts were operationally defined as 
regions with close apposition between an axon terminal and putative granule cell dendrites at which the 
presynaptic and postsynaptic membranes were precisely parallel.  Such contacts generally included a thin 
postsynaptic density and some electron-dense material in the cleft between the membranes.  
For analysis of δ subunit labeling in the Fmr1 WT and KO animals, synapses were classified as 
labeled (immunogold particles at perisynaptic or nearby extrasynaptic sites) or unlabeled (no immunogold 
labeling near the synapse).   For analysis of α4 labeling, gold particle positioning along the synaptic 
membranes was classified as either perisynaptic or synaptic. Labeling was operationally defied as 
perisynaptic if the gold particles were located either directly at the ends of the synaptic contact, within 30 
nm of the ends of the synaptic contact, or along the extrasynaptic membranes that extended up to 100 nm 
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beyond the end of the synapse.  Gold particles that were located at extrasynaptic sites farther than 100 nm 
from the ends of a synaptic contact were not included in this analysis. Labeling was classified as synaptic 
if gold particles were located directly at synaptic contacts, excluding the perisynaptic sites indicated 
above.  Synaptic labeling was further described as within the center third or outer thirds of the synaptic 
density.   
Electrophysiology 
Tonic inhibition in granule cells of the dentate gyrus was studied with in vitro whole-cell recording in 
young adult (2 month) Fmr1 WT and KO littermates.  To determine the contributions of the δ subunit to 
GABA-mediated tonic inhibition in the dentate granule cells, the effects of the δ subunit-selective agonist 
THIP (1 µM) and a δ subunit selective allosteric modulator DS2 (5 µM) were studied.    
Brain slice preparation.  Hippocampal slices were prepared from 2 month-old Fmr1 WT and KO 
littermates.  To prepare slices, animals were deeply anesthetized and decapitated, and brains were placed 
in ice-cold, modified artificial cerebrospinal fluid (aCSF) containing 65 mM sucrose, 82.7 mM NaCl, 2.4 
mM KCl, 0.5 mM CaCl2, 6.8 mM MgCl2, 1.4 mM NaH2PO4, 23.8 mM NaHCO3 and 23.7 mM D-glucose 
and saturated with 95% O2/5% CO2.  This solution also served to cut 300 μm-thick coronal or horizontal 
slices containing hippocampus and cortex using a VT-1000 vibratome (Leica).  Brain slices were allowed 
to equilibrate for 30 min at 35°C and then switched to 21–23 °C (RT) in normal aCSF containing 126 mM 
NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 2 mM CaCl2, 2 mM MgCl2, 26 mM NaHCO3 and 10 mM D-
glucose, continuously bubbled with a mixture of 95% O2/5% CO2 gas.   
  Drug applications.  The drugs used in the electrophysiology studies included SR95531, THIP and 
DS2 (all from Tocris Bioscience) and kynurenic acid (Sigma Aldrich).  SR95531, THIP and DS2 were 
dissolved in DMSO and diluted 1:1000 into aCSF before use.  For kynurenic acid, we added the powder 
into the fresh recording buffer at 2 mM working concentration each time.  
 Electrophysiological recording from brain slices.  For in vitro slice studies of tonic inhibition, 
dentate gyrus granule cells were recorded in whole-cell mode using pipettes with a typical resistance of 
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4–5 MΩ when filled with internal solution containing 140 mM CsCl, 4 mM NaCl, 1 mM MgCl2, 1 mM 
QX-314, 10 mM HEPES, 0.1 mM EGTA, 2 mM Mg-ATP, 0.3 mM Na-GTP with pH set to 7.3.  The initial 
studies of tonic current were performed in the absence of added GABA, since ambient GABA in healthy 
slice preparations was sufficient to evoke a distinct tonic baseline shift that could be detected when 
GABAARs were blocked with SR95531.  Such conditions were considered the most physiological and 
avoided the possibility that adding GABA to the bath would desensitize the high affinity δ subunit-
containing receptors (Bright and Smart, 2013).  For subsequent pharmacological experiments, we added 
GABA (5 µM) to the bath in order to increase the size of the tonic current sufficiently to allow 
comparison of the effects of δ subunit-selective modulators in the Fmr1 WT and KO mice.   
 Neurons in all recordings were visualized with an iXon EMCCD camera (Andor Technology) and 
infrared optics on an upright epifluorescence microscope (Axioskop 2 FS, Zeiss).  pCLAMP 8.2 software 
and an Axopatch-1D amplifier were used for electrophysiology (Axon Instruments).  Data were filtered at 
2 kHz and acquired at a sampling rate of 20 kHz.  Solutions were continuously perfused at a rate of 2 
ml/min.  All the drugs used bath applications for at least 5 min to ensure the effect on the recorded slice. 
 Analysis of electrophysiological data.  Tonic GABAAR-mediated current was defined as the steady-
state current blocked by saturating concentrations of SR95531, and its magnitude was calculated by 
plotting all-point histograms of relevant 30 sec segments of data.  Graphs for all studies were created in 
OriginPro 8 and assembled in CorelDraw 12.  Normally distributed data were analyzed using unpaired 
Student’s two tailed t tests, with significance declared at p < 0.05.  Nonparametric Mann-Whitney rank 
sum test was used to assess the statistical significance of data deviating from normality.  Data are 
presented as mean ± s.e.m.   
Immunoblotting 
Measurement of surface receptor subunit expression by cross-linking.  To determine cell surface 
protein levels from Fmr1 WT vs KO mice, cross-linking experiments followed by Western blot analysis 
were performed, as described previously (Grosshans et al., 2002).  Briefly, 400 µm thick coronal 
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hippocampal slices were prepared using a tissue chopper (VT1200S, Leica).  Slices were incubated either 
in ice-cold ACSF composed of 124 mM NaCl, 3 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 1 mM KH2PO4, 10 
mM D-glucose, 26 mM NaHCO3 and oxygenated with 95%O2/5% CO2, pH 7.4), or ACSF containing 1 
mg/ml bis(sulfosuccinimidyl)suberate (BS3) (Pierce) at 4°C for 45 min, for measurements of total or 
internal protein, respectively.  The cell-impermeable BS3 bi-functionally cross-links all surface proteins 
leading to large molecular weight aggregates which do not reliably migrate in the gel.  Therefore, only 
internal proteins show up in the gel of the BS3 sample.  The cross-link reaction was quenched with 20 mM 
Tris wash buffer, pH 7.6, and the slices were homogenized in homogenizing buffer containing 10 mM 
Tris, pH 8.0, 1 mM EDTA and 1% SDS.  Protein concentrations were determined using the BCA Protein 
Assay Kit (Pierce).  
SDS-PAGE and Western blot analysis.  Proteins were separated on SDS-polyacrylamide gels (Bio-
Rad) using the Bio-Rad Mini-Protean 3 cell system. Proteins were transferred on a PVDF membrane 
(Bio-Rad) and blocked with 4% nonfat dry milk in TTBS. Blots were incubated overnight at 4°C with 
primary polyclonal rabbit antibodies against the following: δ (aa1-44) (Jones et al., 1997); α4 (aa379-
421) (Ebert et al., 1996); (both at 1 µg/ml, gift of W. Sieghart); α4 (1:1000; Millipore, AB5457); or 
mouse monoclonal β-actin (1:1000; Sigma, A2228), followed by HRP-conjugated secondary antibodies 
(1:5000; Rockland) for 2 h at room temperature. Bands were detected using ECL detection kit (GE 
Healthcare) and exposed to X-ray films (MidSci).  
 Data analysis.  Protein signals were analyzed by densitometry using ImageQuant5.2 (Molecular 
Dynamics). For cross-linking experiments, the signal intensity of bands was normalized to the 
corresponding β-actin signal after background subtraction. Surface protein levels were calculated by 
subtraction of the internal protein signal (from BS3-treated slices) from the respective total protein signal 
(from untreated slices). Statistical comparisons were made by Student’s unpaired t-test and the family-
wise error was controlled by the Bonferroni correction for t tests.  p < 0.0125 was considered statistically 
significant. All values are shown as mean ± SEM with n representing the number of experiments.   
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Results 
δ Subunit labeling is slightly lower in the dentate gyrus of Fmr1 KO mice 
Patterns of δ subunit immunoperoxidase labeling in the dentate gyrus were compared in Fmr1 WT 
and KO littermates at postnatal days (PN) 14, 21, 28, 35 and 60.  In WT animals, the normal pattern of δ 
subunit labeling in the hippocampus was evident as early as PN14, although the immunoreactivity 
appeared slightly lower at the young ages and progressively increased at older ages (Fig. 1).  Labeling 
was highest in the molecular layer of the dentate gyrus, where the δ subunit is normally located on 
dendrites of dentate granule cells (Fig. 1).  Very low levels of labeling were found in the hilus and CA3 
region, with slightly higher labeling in CA1.   
The broad patterns of labeling were similar in WT and KO mice at all ages studied (illustrated for 
PN 14, 21, 35 and 60 in Fig. 1).  However, the level of labeling in the molecular layer of the dentate gyrus 
appeared consistently lower in the KO animals when compared to their WT littermates, although the 
differences were slight (Fig. 1).  Densitometric analyses of the immunohistochemical labeling in the mice 
at PN 35 (n = 4 WT and 4 KO) and PN 60 (n = 3 WT and 4 KO) confirmed lower levels of labeling in the 
Fmr1 KO animals compared to their WT littermates (PN 35, 15.1% lower, p <0.05; PN 60, 15.2% lower, 
p <0.05) (Fig. 1I).   
Immunolabeling for the α4 subunit in WT animals closely resembled that of the δ subunit in the 
hippocampus (Fig. 2; compare with Fig. 1).  No differences in the patterns or levels of α4 labeling were 
observed in WT and Fmr1 KO mice, and densitometric analysis revealed no significant differences (Fig. 
2).   
These immunohistochemical findings raised questions about the functional effects of the limited 
decreases in δ subunit expression on tonic inhibition in dentate granule cells.  
δ subunit-containing GABAAR-mediated tonic inhibition is severely reduced in Fmr1 KO mice. 
 To determine if tonic inhibition was altered in the dentate granule cells, we made whole-cell 
recordings from these neurons in young adult (2 month) Fmr1 WT and KO littermates.  We found 
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significantly lower GABAAR-mediated tonic currents in Fmr1 KO mice (31.1 ± 2.4 pA in WT mice vs 
6.7 ± 1.4 pA in KO littermates (p < 0.0001) (Fig. 3A,B).  Similar differences were found in tonic 
inhibitory conductance (11.4 ± 1.3 S/F in WT mice and 2.4 ± 0.5 in KO mice; p < 0.0001) (Fig. 3B).  
These marked differences in tonic current and conductance were observed without any change in 
membrane properties as no differences were observed in either membrane resistance or membrane 
capacitance in the two groups of mice (Fig. 3C). 
 To further probe the function of δ subunit-containing GABAARs in these animals, we next tested the 
efficacy of THIP, a δ subunit-preferring agonist at low concentrations (Jia et al., 2005; Meera et al., 
2011).  In WT animals, THIP (1 μM) substantially increased tonic current, as expected in animals with 
normal levels of δ subunit-containing receptors (Fig. 4).   In contrast, in Fmr1 KO mice, THIP-activated 
currents were small, consistent with low levels of δ subunit-containing GABAARs (-19.8 ± 1.8 pA in WT 
and -8.5 ± 2.0 pA  in Fmr1 KO mice, p = 0.0007) (Fig. 4).  Normalized to baseline tonic current, the 
THIP-activated current was approximately 2.2-fold larger in WT than in Fmr1r1 KO mice (84% 
enhancement in WT vs 38% enhancement in KO mice; p = 0.0154) (Fig. 4).  
To further evaluate the δ subunit contribution to the lower tonic current in the Fmr1 KO mice, we 
studied the effects of the δ subunit-selective GABAAR positive allosteric modulator DS2 (Jensen et al., 
2013; Wafford et al., 2009).  The DS2-enhanced current was significantly larger in the WT than in the 
Fmr1 KO mice (-19.0 ± 3.2 pA  in WT and -9.3 ± 2.0 pA in KO mice; p = 0.019) (Fig. 5).  This 
represented a 3-fold greater enhancement in the WT compared to that in the Fmr1 KO mice (95% 
enhancement in WT vs 32% enhancement in KO mice; p = 0.0126) (Fig. 5).   
Together these electrophysiological findings suggest that δ subunit-containing GABAAR-mediated 
tonic inhibition is severely reduced in dentate granule cells in the Fmr1 KO mice compared to that in WT 
littermates.  The substantial decrease in tonic inhibition differed markedly from the limited decreases in δ 
subunit expression in the immunohistochemical experiments.  These discrepant findings suggested that 
additional alterations, beyond a basic reduction in the δ subunit protein, could be contributing to the 
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functional changes in tonic inhibition.   This led to immunoblotting experiments to evaluate potential 
differences in both total and surface protein levels in WT and Fmr1 KO littermates.  
Cell surface protein levels of the δ  subunit are significantly reduced in Fmr1 KO mice 
 To determine the total and surface expression of the δ subunit, we conducted cross-linking 
experiments followed by Western blot analysis.   We found a 31.4% but non-significant (p = 0.0726, 
unpaired t-test) decrease in total δ subunit protein in the Fmr1 KO mouse (Fig. 6).   However, a four-fold 
decrease in surface expression of the δ subunit was found in the Fmr1 KO mice (p < 0.0032, unpaired t-
test) (Fig. 6).  Because the α4 subunit is a major partner of the δ subunit in the forebrain (including 
dentate granule cells), the levels of α4 subunit were also studied.  The level of total α4 protein in the KO 
animals did not differ significantly from that in the WT mice (p = 0.971, unpaired t-test) (Fig. 6).  
Likewise, no significant differences were found in levels of α4 subunit surface protein between WT and 
KO mice (p = 0.981, unpaired t-test) (Fig. 6).  These findings suggested that the differences in δ subunit-
mediated tonic inhibition could be related to reduced surface expression of the δ subunit in the Fmr1 KO 
mouse, and this led to questions about the subcellular localization of both the δ and α4 subunits.    
Immunogold labeling of the δ subunit is severely reduced near synaptic contacts on dentate granule cells 
in Fmr1 KO mice 
Light microscopic studies did not allow a distinction between localization of the subunits within the 
cytoplasm or near synaptic sites on the surface of the granule cell dendrites.  Postembedding immunogold 
labeling was thus used to determine if there were alterations in the subcellular localization of the δ and α4 
subunits.  After immunolabeling for the δ subunit, symmetric synapses in the dentate molecular layer 
were identified, and the presence or absence of immunogold particles was determined at each symmetric 
synapse that exhibited a clear postsynaptic density.  In WT littermates (n = 3 mice; 183 total synapses), 
immunogold particles were found in perisynaptic locations in 83.8% of the synapses, while 16.2% of 
symmetric synapses were unlabeled (Fig. 7).  In contrast, in the Fmr1 KO mice (n = 3 mice; 212 total 
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synapses), only 24.6% of the symmetric synapses showed immunogold labeling along the plasma 
membrane at perisynaptic sites, and 75.4% of the symmetric synapses showed no immunogold labeling 
either at or near the synaptic contacts (Fig. 7).  Differences in numbers of labeled and unlabeled synapses 
in the two groups of animals were highly significant (Student’s t-test, p < 0.001). 
 These findings are consistent with the biochemical findings of significantly lower surface expression 
of the δ subunit in the Fmr1 KO mice and demonstrate that a reduction occurs at perisynaptic sites where 
δ subunit-containing receptors normally mediate tonic inhibition.   
Immunogold labeling of the α4 subunit is retained at the cell surface but is altered in synaptic location in 
Fmr1 KO mice 
 The α4 subunit is a major partner of the δ subunit in dentate granule cells, and the severe decrease in 
surface labeling of the δ subunit led to questions about the localization of the α4 subunit.  Thus similar 
immunogold labeling was used to determine the localization of the α4 subunit.  In Fmr1 WT littermates, 
78.8% of the symmetric synapses (n = 3 mice; 101 total synapses) showed immunogold labeling at 
perisynaptic or extrasynaptic locations, while 21.2% exhibited labeling directly at the synaptic contacts, 
with labeling at either the center third (19.5%) or outer third (1.7%) (Fig. 8).  In contrast, in the Fmr1 KO 
mouse, 80.3% of the symmetric synapses (n = 3 mice; 116 total synapses), showed α4 subunit labeling 
directly at the synaptic contacts, at either the center third (71.9%) or outer third (8.4%) (Fig. 8).  Labeling 
at perisynaptic or nearby extrasynaptic locations was found in only 19.7% of the total symmetric synapses 
in Fmr1 KO mice (Fig. 8).  These findings suggest that, while surface expression of the δ subunit is 
altered in the Fmr1 KO mouse, surface labeling of the α4 subunit is maintained, but the location of the α4 
subunit is altered, possibly due to lack of δ subunit partnership at perisynaptic sites.   
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Discussion  
This study provides the first evidence for decreased neuronal cell surface expression of the δ subunit of 
the GABAAR in a model of FXS.  The major findings of the study are that 1) δ subunit-mediated tonic 
inhibition in dentate granule cells is substantially lower in Fmr1 KO mice than in WT littermates; 2) 
surface expression in the δ subunit is reduced in the dentate gyrus of the Fmr1 KO mice, as demonstrated 
by both biochemical and immunogold labeling studies; and 3) the substantial decrease in δ subunit 
surface expression contrasts with the limited decrease in total δ subunit protein and immunolabeling in 
the dentate molecular layer.  Together the findings suggest that the decrease in tonic inhibition in the 
dentate gyrus is due primarily to a decrease in surface expression of δ subunit-containing receptors rather 
than a reduction in δ subunit protein alone.     
 The marked reduction in tonic inhibition in dentate granule cells in this model of FXS could have 
important functional effects as the granule cells control the massive input from the entorhinal cortex and 
can thus limit the information that reaches the hippocampus (Dengler and Coulter, 2016; Leutgeb et al., 
2007).  This filtering function of the dentate gyrus provides a critical early step in information processing 
within the hippocampal formation.  Reduced tonic inhibitory control of dentate granule cells could 
negatively impact learning and memory as well as increase seizure susceptibility and levels of anxiety 
(Lee et al., 2016; Maguire et al., 2005; Whissell et al., 2013).  A decrease in tonic inhibition has been 
found previously in other brain regions in mouse models of FXS, including the subiculum (Curia et al., 
2009), basolateral nucleus of the amygdala (Martin et al., 2014; Olmos-Serrano et al., 2010), and the CA1 
region of the hippocampus (Sabanov et al., 2016).  The current findings support the suggestion that a 
decrease in tonic inhibition could be a common finding in FXS, occurring across multiple brain regions 
where the deficits could contribute to several behavioral features of FXS, including hyperexcitability, 
hypersensitivity, and increased seizure susceptibility (Martin et al., 2014; Paluszkiewicz et al., 2011; 
Whissell et al., 2015).  The current electrophysiological studies also confirm that the altered tonic 
inhibition in dentate granule cells of the Fmr1 KO mouse results from deficits in δ subunit-containing 
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GABAARs, as demonstrated by reduced responses to both THIP, a δ subunit-preferring agonist at low 
(µM) concentrations (Jia et al., 2005; Meera et al., 2011), and DS2, a δ subunit-selective positive 
allosteric modulator of GABAARs (Jensen et al., 2013; Wafford et al., 2009). 
Alterations in the δ subunit of the GABAAR in FXS has been suspected for some time, following the 
discovery that the δ subunit mRNA is one of the direct targets of FMRP, as demonstrated initially by 
antibody-positioned RNA amplification methods (Miyashiro et al., 2003) and subsequently by 
electrophoretic mobility shift assays (Braat et al., 2015).  Lower levels of δ subunit mRNA have also been 
found in Fmr1 KO mice in several forebrain regions, including the cerebral cortex and subiculum (Braat 
and Kooy, 2015; D'Hulst et al., 2006; Gantois et al., 2006). 
Descriptions of decreased δ subunit mRNA have led to the frequent assumption that the δ protein is 
also decreased.  However, studies of the δ subunit protein have been limited, and the findings have 
differed among brain regions and ages.   Decreases in the δ subunit protein in Fmr1 KO mice have been 
found in preparations of the entire forebrain at PN12, but not at PN5 or in adults (Adusei et al., 2010), in 
the subiculum in young adult animals (Curia et al., 2009), and in the hippocampus at PN22 (Sabanov et 
al., 2016).   
No detailed immunohistochemical studies of δ subunit expression in the Fmr1 KO mouse have been 
published, but, based on previous biochemical studies and the electrophysiological findings in the current 
study, a substantial decrease in δ subunit labeling was expected.  Surprisingly, δ subunit labeling in the 
dentate gyrus was only slightly, though consistently, lower in the Fmr1 KO mice when compared with 
WT littermates.  Likewise, only a small, statistically nonsignificant, decrease in total δ subunit protein 
was detected in the current biochemical studies.     
A previous study of tonic inhibition and δ subunit expression in the subiculum of Fmr1 KO mice 
found remarkably similar discrepancies between a very large decrease in tonic inhibition in subicular 
neurons (~91% lower than in control mice) and a more limited underexpression of the δ protein in this 
region (~28% lower) (Curia et al., 2009).  Surface expression of the δ subunit was not determined in the 
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previous study.  However, based on the similarities to the present findings, it is plausible that a decrease 
in surface expression of the δ subunit also occurs in the subiculum of Fmr1 KO mice and, potentially, 
other brain regions where δ subunit-containing GABAARs mediate tonic inhibition.   
Significantly lower δ subunit protein expression was recently found in the hippocampus of Fmr1 KO 
mice at PN22 (Sabanov et al., 2016), and it is likely that the brain samples included the dentate gyrus.  δ 
subunit levels were determined in a Triton-insoluble fraction which could have been enriched in 
membranes, allowing detection of significant differences between KO and WT mice.  However, total and 
surface protein levels were not distinguished.  
The lower surface expression of the δ subunit in the Fmr1 KO mice led to questions about the 
expression and localization of the α4 subunit of the GABAAR, as the α4 subunit is the normal partner of 
the δ subunit in dentate gyrus granule cells and is also normally localized primarily at perisynaptic 
locations on granule cell dendrites (Zhang et al., 2007).  No differences were observed in light 
microscopic immunohistochemical labeling of the α4 subunit, and no significant changes in α4 subunit 
levels were found in biochemical studies of either total or surface expression of this subunit in the 
hippocampus of the Fmr1 KO mice.  Consistent with such findings, immunogold labeling was evident 
along the plasma membrane of granule cell dendrites.  However, the location of the α4 subunit was 
altered in the Fmr1 KO mouse.  Rather than being localized at the normal perisynaptic location in dentate 
granule cells, immunogold labeling of the α4 subunit was found directly at synaptic contacts.  A similar 
change in α4 subunit localization was found previously in a rat hyperexcitability model of alcohol 
withdrawal syndrome in which δ subunit-mediated tonic inhibition was also reduced (Liang et al., 2006).  
Such changes in α4 subunit localization, presumably related to the reduced surface expression of the δ 
subunit, may reflect a change in α4 subunit partnership within GABAARs, from predominant partnership 
with the δ subunit at perisynaptic locations to increased partnership with the γ2 subunit directly at 
synaptic contacts. 
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This idea is based on previous suggestions that, during development, the δ and γ2 subunits compete 
with each other for partnership with α4 in GABAARs (Tretter et al., 2001). In the forebrain, including the 
dentate gyrus, partnership of the δ and α4 subunits normally predominates (Sur et al., 1999), and the two 
subunits have very similar regional and cellular localizations (Peng et al., 2002; Pirker et al., 2000).  
However, when the δ subunit is deficient, as in the δ subunit KO mouse, expression of the γ2 subunit 
increases (Peng et al., 2002), consistent with the formation of α4/β/γ2 GABAARs.  Also, in a mouse 
model of epilepsy in which δ subunit expression is decreased during the chronic period, the levels of both 
α4 and γ2 are increased (Peng et al., 2004; Rajasekaran et al., 2010), possibly resulting in increased 
partnership of these subunits.  Similar decreases in δ subunit expression and associated increases in α4 
and γ2 expression have been observed following acute and chronic alcohol administration in rodent 
models of alcohol withdrawal (Lindemeyer et al., 2014; Shen et al., 2011).  In all of these models in 
which the δ and α4 subunits are altered, network excitability was increased (Houser et al., 2012; Olsen 
and Spigelman, 2012; Peng et al., 2004; Spigelman et al., 2003)   
The basic mechanisms underlying the decrease in surface expression of the δ subunit are unknown.  
The reduced surface expression could be related to deficits in activity-dependent transport of FMRP and 
its δ subunit mRNA cargo to local translation sites near GABAergic synapses.  Indeed, the δ subunit 
mRNA was one of the select FMRP targets for which stimulus-induced dendritic mRNA transport was 
impaired in cultured hippocampal neurons from Fmr1 KO mice (Dictenberg et al., 2008).  Alternatively, 
the lack of surface expression could reflect either a deficit in trafficking of the δ subunit-containing 
receptors to the dendritic surface or increased endocytosis of these receptors (Gonzalez et al., 2012; Shen 
et al., 2011).  While the basic mechanisms could be related directly to the δ subunit, alterations in 
associated subunits, such as altered phosphorylation of the β3 subunit, as observed in Fmr1 KO mice 
(Vien et al., 2015), could also play a role.  The possibility of identifying the underlying mechanisms and 
finding ways to increase surface expression of δ subunit-containing GABAARs is particularly intriguing 
since the current findings indicate that a substantial amount of δ subunit protein is present in the neurons 
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but fails to reach its normal localization at the dendritic surface.  Interestingly, there are other examples of 
decreased surface expression of membrane-associated proteins in Fmr1 KO mice, including the AMPA 
receptor subunit GluR1 in the lateral amygdala, in this case possibly related to excessive mGluR signaling 
(Suvrathan et al., 2010).     
 The identification of deficits in tonic inhibition in an additional brain region provides further support 
for the development of pharmacological agents that could selectively enhance tonic inhibition.  Despite 
lower δ subunit expression in the dentate gyrus, a δ subunit-preferring agonist, THIP, and a δ subunit-
selective positive allosteric modulator, DS2, increased tonic currents in dentate granule cells of Fmr1 KO 
mice, although the enhancement was less than that in WT granule cells.  Despite the reduced surface pool 
of δ subunit-containing GABAARs, THIP augmented tonic inhibition and reduced hyperexcitability of 
principal cells of the basolateral nucleus of the amygdala of Fmr1 KO mice in brain slices (Olmos-
Serrano et al., 2010), and also reduced some behavioral deficits, including hyperexcitability, in vivo 
(Olmos-Serrano et al., 2011).   At low (micromolar) concentrations, THIP could be exerting its effects 
primarily at remaining δ subunit-containing nonsynaptic receptors to increase tonic inhibition.  However, 
at higher concentrations, THIP could be activating other GABAARs that do not contain the δ subunit. 
Neurosteroids are also major positive allosteric modulators of GABAARs and many, such as 
tetrahydrodeoxycorticosterone (THDOC), have high efficacy at nonsynaptic δ subunit-containing 
receptors (Stell et al., 2003; Wohlfarth et al., 2002).  However, all neuroactive steroids, including 
allopregnanolone and a synthetic analog, ganaxolone, can modulate both nonsynaptic and synaptic 
GABAARs (Carter et al., 1997; Reddy and Estes, 2016).  In previous behavioral studies in Fmr1 KO 
mice, acute administration of ganaxolone prevented audiogenic seizures (Heulens et al., 2012) and 
reduced repetitive, perseverative behavior (Braat et al., 2015).  Enhanced tonic inhibition could have 
contributed to the behavioral changes, but increased phasic inhibition at synaptic receptors could also play 
a role.  Ganaxolone is currently in a phase II clinical trial for treatment of children with Fragile X 
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(ClinicalTrials.gov Identifier NCT01725152) while THIP is in a trial for Angelman Syndrome   
(ClinicalTrials.gov Identifier NCT02996305). 
 The search for synthetic neurosteroids with selective actions at nonsynaptic GABAARs has led to the 
development of a new positive allosteric modulator of GABAARs, SGE-812 (Martin et al., 2016).  This 
compound is highly selective for δ/α4 subunit-containing GABAARs at low concentration and increased 
tonic inhibition in principal neurons of the basolateral nucleus of the amygdala in slices from Fmr1 KO 
mice.  Whether such synthetic neuroactive steroids are acting at remaining perisynapic α4/δ-expressing 
GABAARs or potentially at other α4-containing receptors is unclear (Martin et al., 2016).  However, such 
GABAAR modulators hold promise for the treatment of FXS by increasing tonic inhibition at δ or α4 
subunit receptors and thus providing a more limited and targeted approach to GABAAR-mediated 
treatment.   
 Beyond the direct effects of neuroactive steroids as positive allosteric modulators of GABAARs, 
some neurosteroids such as THDOC can increase the trafficking and membrane insertion/stabilization of 
α4 subunit-containing GABAARs in hippocampal neurons apparently through protein kinase C (PKC)-
dependent phosphorylation of the α4 and β3 subunits (Abramian et al., 2014; Abramian et al., 2010; 
Adams et al., 2015).  Recently, allopregnanolone and another new synthetic neuroactive steroid, SGE-
516, were also found to increase the surface expression of α4/β/δ subunit-expressing receptors in dentate 
granule cells, possibly involving PKC-dependent phosphorylation of the β3 subunit (Modgil et al., 2017).  
Thus some endogenous and synthetic neurosteroids (although not ganaxolone) could enhance tonic 
inhibition by both direct modulatory effects on nonsynaptic GABAARs and enhanced trafficking and 
surface expression of these receptors (Modgil et al., 2017).  Considering the current findings of lower 
surface expression of the δ subunit in Fmr1 KO mice, it would be particularly interesting to learn if such 
compounds can increase δ subunit-containing GABAARs at nonsynaptic sites along the membrane and 
enhance tonic inhibition in this mouse model of FXS.    
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Findings of this study suggest that altered surface expression of the δ subunit of the GABAAR, rather 
than a decrease in δ subunit expression alone, is likely limiting tonic inhibition in the dentate gyrus in this 
model of FXS.  Whether deficits in surface expression are confined to the δ subunit or could be found for 
additional receptor proteins that require trafficking to and insertion at the membrane surface in FXS 
remains to be determined.  The findings add to the growing number of GABA system alterations that have 
been identified in models of FXS and suggest novel treatment approaches for this disorder. 
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Figure Legends 
Fig. 1.  Immunolabeling of the δ subunit in the dentate gyrus is slightly lower in Fmr1 KO mice than in 
WT littermates at PN14-PN60.  (A,C,E,G) In WT animals, the δ subunit is strongly expressed in the 
molecular layer of the dentate gyrus (M).  Labeling is very low in the hilus (H) and CA3, but slightly 
higher in CA1.  Similar patterns of labeling are evident from PN14 to PN60, but the level of δ subunit 
labeling in the molecular layer increases throughout this period and labeling of interneurons appears 
strongest at PN14.  (B,D,F,H)  In Fmr1 KO animals, the patterns of δ subunit labeling closely resemble 
those of the WT littermates at each age.  However, slightly lower levels of labeling are found in the 
dentate molecular layer in the KO animals.  (I) Densitometry confirmed small but significant differences 
in labeling intensity in the molecular layer at PN35 and PN60.  Mean intensities of labeling for WT and 
KO littermates at four ages are included in the bar graph.  However, only data from animals at PN35 and 
PN60 were analyzed statistically due to limited numbers of littermates at younger ages.  *p < 0.001.   
Scale bar = 100 µM (A-H).    
 
Fig. 2.  Immunolabeling of the α4 subunit in the dentate gyrus is similar in Fmr1 WT and KO mice at 
PN35.  (A,B) α4 labeling is highest in the molecular layer (M) of the dentate gyrus in WT and KO mice, 
and the pattern of α4 labeling closely resembles that of the δ subunit (see Fig. 1E,F).  The level of α4 
labeling in the molecular layer is similar in WT and KO littermates.  (C) Densitometry demonstrated no 
significant difference in the mean intensity of α4 labeling in the molecular layer of WT and KO 
littermates.  Scale bar = 100 µM (A,B). NOTE, “C” is not visible in Figure. 
 
Fig. 3.  GABAAR-mediated tonic current in dentate granule cells is significantly lower in Fmr1 KO mice 
than in WT littermates.  (A) Example traces from WT (top) and Fmr1 KO (bottom) dentate gyrus granule 
cells demonstrate a large tonic current that is sensitive to the GABAAR antagonist SR 95531 in WT but 
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not in the KO cell.  To the right are all points histograms of the current levels prior to (black) and 
following application of SR 95531 (grey).  (B) Summary of the mean ± s.e.m. levels of SR 95531-
sensitive tonic current (left) and conductance (right) in WT and KO conditions. Significant reductions in 
current and conductance were observed in the KO relative to WT cells.  (C) No significant differences 
were observed in basic membrane properties of membrane resistance (left) or capacitance (right) when 
comparing WT and KO granule cells. 
 
Fig. 4.  Activation of GABAAR-mediated current by the δ subunit-selective agonist THIP is significantly 
decreased in Fmr1 KO mice.  Example traces shown on the left indicate the current activated by 
application of 1 µM THIP, an agonist selective for δ subunit-containing GABAARs.   A recording from a 
WT granule cell is shown on the top and a KO granule cell on the bottom.  To the upper right are 
summaries of the levels of current activated by THIP in each condition (mean ± s.e.m.).  Open symbols 
indicate individual cells. On the lower right is a summary of the amount, expressed as a percentage, of 
additional current activated by THIP relative to the SR 95531-sensitive tonic current level prior to THIP.  
 
Fig. 5.  Enhancement of GABA-mediated tonic current by the δ subunit-selective positive allosteric 
modulator DS2 is significantly decreased in Fmr1 KO mice.  Example traces shown on the left indicate 
the current activated by application of DS-2, a positive modulator selective for δ subunit-containing 
GABAARs.  A recording from a WT granule cell is shown on the top and a KO granule cell on the 
bottom.  To the upper right are summaries of levels of current increase observed in DS-2 in each 
condition (mean ± s.e.m.).  Open symbols indicate individual cells.   On the lower right is a summary of 
the percent increase in SR 95531-sensitive tonic current following DS2 application. 
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Fig. 6.  Surface expression of the GABAAR δ subunit is decreased in Fmr1 KO mice.  (A) Representative 
Western blots for δ (left panel) and α4 (right panel) after cell surface cross-linking (t = amount of total 
protein; int = amount of internal protein).  The respective β-actin signals are shown below.  (B) 
Quantification of the total and surface δ subunit levels.  Surface protein levels were calculated by 
subtracting internal protein signal from the total protein signal.  A four-fold decrease in surface 
expression of the δ subunit was found in the KO mice.  (C) Quantification of the total and surface α4 
subunit levels of WT vs KO.  No differences in total or surface expression of α4 subunit protein were 
found in WT and KO mice.  Data are mean ± SEM, n = 5-8 mice/group.  * p < 0.0125, unpaired t-test  
between KO and WT.    
 
Fig. 7.  Immunogold labeling of the δ subunit is decreased along the dendritic plasma membrane in Fmr1 
KO mice.  (A,C)  In Fmr1 WT mice, δ subunit immunogold labeling is localized predominantly at 
perisynaptic locations (arrows) near symmetric synapses (open arrowheads; T = axon terminal).  (B,D) In 
Fmr1 KO littermates, many symmetric synapses (open arrowheads) lack δ subunit immunogold labeling 
at perisynaptic sites.  Immunogold particles were occasionally observed within the cytoplasm of granule 
cell dendrites (arrow in panel D).  (E) Quantitative analysis in WT animals demonstrated δ subunit 
immunogold labeling at perisynaptic locations in a high percentage of symmetric synapses (identified as 
labeled synapses).   In contrast, a high percentage of symmetric synapses in Fmr1 KO mice lacked 
labeling at the synaptic membrane (identified as unlabeled synapses).  Scale bars = 0.2 µM (A-D).       
 
Fig. 8.  Immunogold labeling of the α4 subunit is decreased at perisynaptic locations but increased at 
synaptic sites in Fmr1 KO mice.  (A,C)  In WT mice, labeling for the α4 subunit was found primarily at 
perisynaptic (arrow in panel A) or extrasynaptic (arrow in panel C) locations near symmetric synapses 
(open arrowheads).  (B,D) In Fmr1 KO animals, α4 subunit immunogold labeling (arrows) was 
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frequently found directly at synaptic contacts (open arrowheads).  (E) Quantitative analysis of α4 labeling 
in WT animals demonstrated immunogold particles directly at synaptic contacts in a high percentage of 
symmetric synapses.  (F)  Immunogold labeling of the α4 subunit is found predominantly at perisynaptic 
locations in Fmr1 WT animals but near the center of symmetric synapses in Fmr1 KO animals.  Lower 
percentages of synapses were labeled at other synaptic or nonsynaptic locations in both groups of animals.  
Scale bars = 0.1 µM (A-D) 
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